Menu

CME Corner

Active Programs

Motivational Interviewing to Support Shared Decision Making in MS
First Question: Should I Start Treatment?

This activity, the first in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the practice of motivational interviewing (MI) and how it can help clinicians prompt patients to think about their diagnosis and therapeutic options. The management of MS is increasingly challenging due to the wide variation in the clinical course for each patient, an increas ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Shared Decision Making at the Crossroads: Adjusting MS Therapy Next Question: When Is it Time to Adjust Therapy?

This activity, the third in a 3-part series focused on shared decision making and patient-centered care in MS, will examine how to assess outcomes of DMT therapy from both patient and clinician perspectives, as well as practical strategies for working with patients to adjust therapy when necessary. ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Shared Decision Making in Selecting Initial MS Disease-Modifying Therapy
Next Question: Which Disease-Modifying Therapy Should I Try First?

This activity, the second in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the differences in MS disease-modifying therapies (DMT) and provide guidance for working together with patients to select appropriate first-line treatment. ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Clinical Insights in Pediatrics: Diagnosing and Managing Pediatric Epilepsy

In the United States, an estimated 460,000 children have active epilepsy, and approximately 750,000 children have a history of epilepsy. Epilepsy is a complex disorder that requires careful monitoring and management. Newer pharmacologic options for the treatment of focal and generalized seizures may provide more effective treatment options in the pediatric population. In addition to managing epile ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Preventing Stroke in Atrial Fibrillation

Individuals with atrial fibrillation (AF) have a 4 to 5 times greater risk for ischemic stroke and tend to experience more serious strokes than those without AF. Although most strokes related to AF could be prevented with appropriate anticoagulation therapy, many patients are not receiving it. The goal of this activity is to help clinicians evaluate and optimally manage stroke risk in their patien ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Stroke Prevention in Atrial Fibrillation: Tailoring Anticoagulation Therapy for Optimal Outcomes

A CPE-certified interactive newsletter with highlights from the American Society of Consultant Pharmacists workshop. Although most AF-related strokes can be prevented with anticoagulation medication, many older adults are not receiving optimal evidence-based therapy for stroke prevention. This activity will address persistent barriers to the appropriate use of anticoagulation therapy for the p ...

  • i-Newsletter
  • ACPE

Expired Programs

Advances in Multiple Sclerosis: Current Best Practices, Ongoing Challenges, and Future Directions

An estimated 350,000 to 500,000 people in the United States are currently diagnosed with MS, a chronic neurologic disorder with potential for substantial negative impact on quality of life. Treatment is focused on returning function after an attack, preventing new attacks, and preventing disability. The management of MS is increasingly challenging due to heterogeneity in the pathogenesis of MS, wi ...

  • Video Roundtable Video Roundtable
  • ACCME
  • ANCC

Advances in Multiple Sclerosis: Nursing Interventions to Promote Optimal Care

An estimated 350,000 to 500,000 people in the United States are currently diagnosed with MS, a chronic neurologic disorder with potential for substantial negative impact on quality of life. Nurses play an important role in addressing MS symptoms, managing adverse events, limiting disability, and coordinating with the collaborative care team to ensure that patients have the optimal treatment plan a ...

  • i-Newsletter i-Newsletter
  • ANCC

Advances in Multiple Sclerosis: Optimizing Disease-Modifying Therapy

Multiple sclerosis is a chronic neurologic disorder with potential for substantial negative impact on quality of life. Treatment seeks to return function after an attack, prevent new attacks, limit disability progression, and improve quality of life. The management of MS is complex because of the variability in the clinical course for each patient, emerging therapies, and patient characteristics a ...

  • i-Newsletter i-Newsletter
  • ACCME

Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation

Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 million people in the United States. Individuals with AF have 4 to 5 times greater risk for ischemic stroke and tend to experience more serious strokes than those without AF. Although most AF-related strokes could be prevented with anticoagulation therapy, ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Clinical Insights in Migraine Management: Evolving Approaches to Migraine Treatment and Adherence

Migraine affects between 11% and 16% of adults in the United States. This condition is associated with a significant societal and economic burden. There are many pharmacologic and nonpharmacologic treatment options for both chronic and episodic migraine, and clinicians should tailor these therapies to individual patient characteristics as well as disease severity and patterns. Additionally, patien ...

  • i-Newsletter i-Newsletter
  • ACCME

Clinical Insights in Migraine Management: State-of-the-Art Migraine Guidelines Review

Migraine affects between 11% and 16% of adults in the United States. This condition is associated with a significant societal and economic burden. On an individual level, chronic migraine is associated with reduced health-related quality of life and increased psychiatric and medical comorbidities. Guidelines provide definitions and diagnostic criteria for types of migraine and can aid clinicians i ...

  • i-Newsletter i-Newsletter
  • ACCME

Direct-acting Oral Anticoagulants and Guideline Updates: Preventing Stroke in Older Adults with Atrial Fibrillation

A CPE-certified online monograph with highlights from the American Society of Consultant Pharmacists workshop. Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 million people in the United States. AF is an independent risk factor for ischemic stroke severity, recurrence, and mortality. AF is a disease ...

  • e-Monograph e-Monograph
  • ACPE

Improving Women's Health Outcomes in MS: A Multidisciplinary Approach

Multiple sclerosis (MS) is a chronic neurologic disorder with potential for substantial negative impact on quality of life. MS is nearly 3 times more common in women compared with men and is typically diagnosed between the ages of 20 and 50. Since the diagnosis and treatment of MS frequently occur during womenís reproductive years, clinicians often face questions about MS treatment as it relates t ...

  • Video Roundtable Video Roundtable
  • ACCME

Patient-Centered Care for Nonmotor Symptoms of Parkinson's Disease: Updates for Current Practice and Emerging Therapies

Approximately 1 million US adults have Parkinsonís disease (PD), a progressive neurodegenerative movement disorder that affects motor and cognitive function and significantly impairs quality of life. Nonmotor symptoms can significantly decrease quality of life for patients with advancing disease. These complications can include cognitive, neuropsychiatric, and autonomic symptoms. Available therapi ...

  • i-Newsletter i-Newsletter
  • ACCME

Patient-Centered Care in Early Parkinson's Disease: Updates for Current Practice and Emerging Therapies

Approximately 1 million US adults have Parkinsonís disease (PD), a progressive neurodegenerative movement disorder that affects motor and cognitive function and significantly impairs quality of life. PD can be difficult to diagnose, and it is critical that clinicians recognize symptoms, both motor and nonmotor, to aid in early and accurate diagnosis. Appropriate treatment initiation based on patie ...

  • i-Newsletter i-Newsletter
  • ACCME

Patient-Centered Care in Moderate to Advanced Parkinson's Disease: Updates for Current Practice and Emerging Therapies

Approximately 1 million US adults have Parkinsonís disease (PD), a progressive neurodegenerative movement disorder that affects motor and cognitive function and significantly impairs quality of life. Treatment of advancing disease can be complicated because clinicians must manage both motor deterioration and nonmotor symptoms. Long-term treatment carries significant complications that can exacerba ...

  • i-Newsletter
  • ACCME
Main Menu
EDITOR'S PICKS